Options for Transplant-Ineligible Myeloma Patients - HealthTree for Multiple Myeloma
[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

New Options for Transplant-Ineligible or Deferred Multiple Myeloma Patients: Recent Trial Insights

New Options for Transplant-Ineligible or Deferred Multiple Myeloma Patients: Recent Trial Insights image

New Options for Transplant-Ineligible or Deferred Multiple Myeloma Patients: Recent Trial Insights

Immunotherapy (CAR T, Bispecifics and more) Treatment
event Feb 11, 2025 11:00AM - Feb 12, 2025 12:00PM EST
link icon facebook logo X logo linkedin logo reddit logo email icon
videocam
Can't make it to the event?
We send a recording to all registered participants of the event!

Event Description

Join us for an insightful webinar featuring Dr. Marc Braunstein as he delves into the groundbreaking results of the CEPHEUS trial, focusing on treatment for newly diagnosed multiple myeloma patients who are transplant-ineligible or deferred. Discover what these findings mean for the future of multiple myeloma care and how they could reshape treatment strategies. Don’t miss this opportunity to gain expert insights and ask your questions live!

 

Schedule & Agenda

The panelist Cynthia Cahoon
Introductions
11:00 AM
Cynthia Cahoon

Cynthia introduces the agenda of the event and featured speaker Dr. Marc Braunstein

The panelist Marc Braunstein, MD, PhD
Presentation
11:05 AM
Marc Braunstein, MD, PhD
 

Join Dr. Marc Braunstein explores CEPHEUS trial results, advancing care for transplant-ineligible multiple myeloma patients.

person
Questions and Answers
11:35 AM
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators

The panelist Cynthia Cahoon
Cynthia Cahoon

Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.

Read Bio
The panelist Marc Braunstein, MD, PhD
Marc Braunstein, MD, PhD

Marc Barunstein, MD, PhD is a board-certified hematologist/oncologist with a long-standing interest in plasma cell disorders. He is a part of the NYU Perlmutter Cancer Center's multiple myeloma and cellular therapy programs and serve as Associate Professor of Medicine at NYU Grossman Long Island School of Medicine where he co-direct the medical school hematology curriculum and also serves as Director of the hematology/oncology fellowship program. His clinical research focus is on the use of novel immunotherapy combinations to treat multiple myeloma. As part of his role, he also focuses on medical education and serves on education committees for the American Society of Hematology and American Society of Clinical Oncology, as well as volunteer committees with the American Society of Clinical Oncology and American College of Physicians. In his free time he volunteers with the Leukemia and Lymphoma Society, spends time with his family, and enjoys playing guitar and mandolin.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

newsletter icon

Get the latest thought leadership on your Blood Cancer delivered straight

By subscribing to the Healthtree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.